Back to All Events

Evolving HCV Management in Harder-to-Treat Populations

Evolving HCV Management in Harder-to-Treat Populations
 

Dr. Kris V. Kowdley

Hosted by the Seattle Science Foundation
Swedish Medical Center, James Tower, Suite 600
Seattle, Washington


Speaker: Dr. Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF
Director, Liver Care Network
Director, Organ Care Research

Are you ready to modify HCV management strategies for your harder-to-treat patients? Join Dr. Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF for lunch and a case-based discussion on treatment decisions for challenging patients including those with cirrhosis, genotype 3 HCV infection, reduced renal function, and HIV/HCV coinfection.

Prepare to integrate the latest clinical data in your practice by attending this interactive presentation and question and answer session. Come prepared to discuss the application of new data and treatment challenges in real patients by reviewing a brief foundational module

RSVP to Paul Albright @ paul@cmmglobal.com or
(512) 301-5032

 

Agenda

11:30 AM – 12:00 PM – Registration
12:00 PM – 1:15 PM – Luncheon Meeting

Overview of Considerations for Harder-to-Treat HCV-Infected Patients

Case-Based Discussion

·       Impact of Cirrhosis and Renal Status on HCV Management
·       Evolving Treatment Strategies for Genotype 3 HCV Infection
·       Key Considerations in Caring for HCV/HIV Coinfection

Question and Answer Session

Posteducation Polling and Closing Remarks

Complete program information is available online at clinicaloptions.com/evolvingHCV.

Earlier Event: September 12
DePuy Synthes Spine Course
Later Event: September 16
Regeneron Luncheon